Company Filing History:
Years Active: 2014
Title: Reuben Achiron: Innovator in Medical Detection Technologies
Introduction
Reuben Achiron is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medical detection technologies, particularly in the identification of meconium in amniotic fluid. His innovative work has the potential to enhance prenatal care and improve outcomes for newborns.
Latest Patents
Reuben Achiron holds a patent for a device and method for the identification of meconium in amniotic fluid. This patent describes methods and devices that utilize an elongated probe for the in vivo detection of meconium in amniotic fluid held in an amniotic sac. The detection is based on identifying the presence of Zinc-coproporphyrin I (ZnCP), which is excited at approximately 405 nm and emits characteristic fluorescence centered at about 580 nm and less intensely at 630 nm. This innovative approach offers a new avenue for monitoring fetal health during pregnancy.
Career Highlights
Reuben Achiron is associated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where he continues to develop and refine his inventions. His work is characterized by a commitment to advancing medical technologies that can significantly impact patient care.
Collaborations
Reuben has collaborated with notable colleagues in his field, including Genady Kostenich and Sol Kimel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Reuben Achiron's contributions to medical detection technologies exemplify the impact of innovation in healthcare. His patent for detecting meconium in amniotic fluid represents a significant advancement in prenatal diagnostics. Through his work, he continues to pave the way for improved medical practices and better health outcomes for mothers and their babies.